CP2C-targeting peptide-based anticancer agent

A CP2c-targeting peptide-fatty acid conjugate, comprising:

• a transcription factor CP2c-targeting peptide comprising the amino acid sequence of SEQ ID NO:
• 2, wherein the N-terminus of the transcription factor CP2c-targeting peptide is modified with an acetyl group;
• a linker peptide at the C-terminus of the transcription factor CP2c-targeting peptide, wherein the linker peptide consists of the amino acid sequence of GnKGm (SEQ ID NO:
• 21), wherein n and m are each independently an integer of 1 to 6;
• a cell-penetrating peptide (CPP) consisting of the amino acid sequence of SEQ ID NO:
• 3 at the C-terminus of the linker peptide, wherein the C-terminus of the cell-penetrating peptide (CPP) is modified with an amide group;
• and
• a fatty acid conjugated with lysine (Lys, K) of the linker peptide, wherein the fatty acid is C16 palmitoyl acid bonded to glutamic acid (Glu, E).